| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 16.75 | 16.38 | 14.93 | 13.00 | 4.95 | 11.04 | 18.39 |
| Depreciation & Amort ($Mil): | 1.30 | 1.30 | 1.43 | 1.01 | 1.07 | 1.50 | 2.43 |
| Operating Income ($Mil): | -2.23 | -8.37 | -10.02 | -15.79 | -15.54 | -9.83 | -5.98 |
| Net Income ($Mil): | -5.68 | -6.96 | -8.82 | -14.85 | -13.90 | -82.31 | -82.31 |
| Earnings Per Share ($): | -0.08 | -0.13 | -0.18 | -0.30 | -0.33 | -0.33 | -2.57 |
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 34.31 | 42.03 | 38.51 | 45.89 | 51.58 | 38.72 | 43.66 |
| Current Liabilities ($Mil): | 2.55 | 6.62 | 5.99 | 9.88 | 5.80 | 4.44 | 8.56 |
| Long Term Debt ($Mil): | 0.00 | 0.00 | 0.73 | 1.96 | 0.00 | 0.00 | 3.42 |
| Shares Outstanding (000): | 63310 | 63170 | 49240 | 49340 | 47290 | 40310 | 32760 |
| Common Equity ($Mil): | 42.81 | 46.84 | 35.89 | 37.99 | 48.90 | 38.86 | 31.60 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | -33.91 | -42.49 | -59.08 | -114.23 | -280.81 | -105.25 | -447.58 |
| Return on Equity (%): | -12.71 | -14.86 | -24.58 | -39.09 | -28.43 | -29.90 | -260.47 |
| Return on Assets (%): | -12 | -12.93 | -16.88 | -24.38 | -20.55 | -20.85 | -131.82 |
| P/E Ratio: | 0 | -9.77 | -10.06 | -13.60 | -13.48 | -9.30 | 0.00 |
| Price/Book: | 1 | 1.71 | 2.48 | 5.30 | 4.30 | 3.18 | 0.00 |
| Debt Equity: | 0.00 | 0.00 | 0.02 | 0.05 | 0.00 | 0.00 | 0.11 |
| Interest Coverage: | 0.00 | -86.00 | -45.42 | -48.50 | -32.90 | -15.84 | -86.56 |
| Book Value ($): | 0.68 | 0.74 | 0.73 | 0.77 | 1.03 | 0.96 | 0.96 |
| Price/Sales: | 5.24 | 2.95 | 5.97 | 15.49 | 42.51 | 11.21 | 0.00 |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN | +12.60 | 58.23 | |
| GILEAD SCIENCES | -1.00 | 46.92 | |
| CELGENE CP | -10.00 | 58.86 | |
| BIOGEN IDEC INC | -31.90 | 43.52 | |
| AMYLIN PHARMA I | -85.70 | 6.41 |
